Treatment Options at Eber Medical Group
| Treatment | Indication | Expected Effect | Cost (CNY) |
|---|---|---|---|
| SCS — Spinal Cord Stimulation | Incomplete paraplegia; chronic pain; bladder dysfunction | Motor recovery (Asia first 2014); pain 50–70% reduction | ~400,000 |
| FSPR | Spastic hemiplegia/paraplegia; spastic hand | Permanent spasticity reduction; fine motor restoration | Inquire |
| Baclofen Pump | Severe diffuse spasticity; intrathecal baclofen | Continuous spasticity control; less oral medication | Inquire |
| Robotic Gait Rehab | Any motor deficit affecting gait | Gait pattern restoration; endurance | Included in rehab |
| TMS (rTMS) | Cortical motor area — promotes neuroplasticity | Improved motor cortex excitability; spasticity reduction | Included in rehab |
| Acupuncture + Tuina (TCM) | Adjunct for all; reduces spasticity, improves circulation | Reduces tone, improves sensation, quality of life | Included in TCM |
Clinical Breakthrough: From Wheelchair to Walking
The effectiveness of Eber's SCS protocol was showcased in a major report by Dragon TV (Shanghai East TV). The feature followed a 24-year-old patient who had been paraplegic for five years following a severe fall.
By implanting a precision spinal cord stimulator and following the Stage 3 rehabilitation program, the patient achieved:
- Independent Walking: Within two months of surgery, the patient was able to stand and walk without a wheelchair.
- Sensory Restoration: Regained significant control over lower limb sensation and autonomic functions (bladder/bowel).
This case was a first in China and remains a gold standard for neuromodulatory recovery in Asia.
The Historic 2014 First-in-Asia SCS
In 2014, Dr. Sun Chenyan performed the first Spinal Cord Stimulation (SCS) surgery for paraplegia in Asia. The patient — completely unable to walk before surgery — regained independent ambulation following the procedure and intensive rehabilitation. This patient later started a family and continues in excellent health over a decade later.
This landmark achievement established Eber Medical Group as Asia's leading center for neuromodulatory treatment of spinal cord injury and motor paralysis.